TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/11/24 16:43 | 3/7/24 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Evanson Jeff | NJ | O | Chief Co | P | 26 | 0.4200 | 0 | 62 | 8 | 808 | D | ||||||||||||||
1/24/23 20:08 | 1/20/23 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Evanson Jeff | NJ | O | Chief Co | S | -296 | 1.11 | 0 | -267 | -26 | 746 | D | ||||||||||||||
1/19/23 20:05 | 1/17/23 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Evanson Jeff | NJ | O | Chief Co | S.m | -204 | 1.24 | 0 | -164 | -14 | 1,013 | D | ||||||||||||||
12/6/21 17:25 | 12/3/21 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Evanson Jeff | NJ | O | Chief Co | P | 47 | 1.34 | 0 | 35 | 3 | 1,177 | D | ||||||||||||||
2/25/21 20:52 | 2/23/21 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Evanson Jeff | NJ | O | Chief Co | S | -18 | 2.09 | 0 | -9 | -1 | 1,142 | D | ||||||||||||||
2/17/21 21:14 | 2/12/21 | OTLK | Outlook Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Evanson Jeff | NJ | O | Chief Co | S | -145 | 2.55 | 0 | -57 | -5 | 1,150 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |